Search the Newsreel

Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions

Fuller Smith & Turner's (LON:FSTA) Soft Earnings Are Actually Better Than They Appear

Full House Resorts Inc. (FLL) Q1 2026 Earnings: EPS Beats Estimates, Stock Declines Amid Uncertain Revenue Picture - Financial Health Score

Fuller, Smith & Turner PLC: Share Buyback Programme

H B Fuller Company (FUL) gains 9.6% over four weeks before earnings

The specialty-chemicals stock has firm weekly momentum, though relative strength remains a complicating signal before the June 24 report.

FLGT Q1 2026 Earnings: Significant EPS Miss, Stock Rises on Potential Strategic Moves - EPS Revision Trend

H B Fuller Company (FUL) carries 29.6% 12-week advance into June 24 results

The specialty-chemicals maker enters earnings with an active trend, but negative Relative Strength and slightly lighter turnover leave the setup mixed.

FULC Q1 2026 Earnings: EPS Beat Despite Pre-Revenue Status, Stock Declines - Tech Earnings Analysis

Q1 Earnings Outperformers: Fulton Financial (NASDAQ:FULT) And The Rest Of The Regional Banks Stocks

UK's Fuller, Smith & Turner gets boost from summer, World Cup demand

Fuller, Smith & Turner cheers solid year, eyes bumper summer

Fuller, Smith & Turner gears up for World Cup gains

Fuller Smith & Turner posts profit beat, extends buyback By Investing.com

FSTA: Adjusted profit before tax rose 28% on 5.7% revenue growth, with EPS up 38%

Fulcrum Therapeutics (FULC) Loses 51% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

A Look At Fulcrum Therapeutics (FULC) Valuation After Scrapping Lead Sickle Cell Drug And Restructuring

What's Going On With Fulcrum Therapeutics Stock On Thursday? - Fulcrum Therapeutics (NASDAQ:FULC)

FULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraud

A Look At Fulcrum Therapeutics (FULC) Valuation After Halting Pociredir And Launching A Broad Review

Full House Resorts Q1 2026 Earnings: Narrower Loss Beats Expectations; Stock Still Declines

Why Fulcrum Therapeutics (FULC) Is Down 53.6% After Ending Pociredir And Exploring Strategic Options

Fulcrum Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Fulcrum Therapeutics, Inc. (FULC)

Full Truck Alliance (YMM) Upgraded to Buy: Here's Why

Fulcrum Lithium (ASX:FUL) Advances Nevada Lithium Project Momentum

Fulcrum Therapeutics (FULC) Hovers Near Support After Marginal Uptick - Covered Call Trade

Why Did Fulcrum Lithium (ASX: FUL) Shares Jump Today?

Full Truck Alliance Q1 2026: 50 Million Orders, 94% Commission Penetration, and a $20 Price Target

Assessing Full Truck Alliance (YMM) Valuation After Recent Share Price Weakness

Full Truck Alliance (YMM): Best New Tech Stocks With Highest Upside Potential

Full Truck Alliance (YMM) Net Margin Above 35% Challenges Bearish Profitability Narratives

Full Truck Alliance tops forecasts as freight orders jump double digits (YMM)

FULL TRUCK ALLIANCE ($YMM) Releases Q1 2026 Earnings

Full Truck Alliance Q1 Earnings Call Highlights

Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Q1 Earnings and Revenues Surpass Estimates

After Plunging 21.5% in 4 Weeks, Here's Why the Trend Might Reverse for Fulcrum Therapeutics (FULC)

Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach